Hence, in this review, we highlighted the important role of miRNAs not only in the current treatments of melanoma metastasis but also their involvement in drug resistance to BRAF and MEK inhibitors, and their role as prognostic factors (biomarkers). This evidence concerns the gene BRAF and melanoma.